Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s LymphomaThomas E. Witzig, Christine A. White, Leo I. Gordon et al.|Journal of Clinical Oncology|2002Cited by 1.2k
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CTTrond Velde Bogsrud, Val J. Lowe, Gregory A. Wiseman et al.|Nuclear Medicine Communications|2007Cited by 107